Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about RHHBY

Recent news which mentions RHHBY

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
This Drug By Roche And Novartis Reduces Allergic Reactions Across Multiple Foods For People With Food Allergies
Tickers NEWS NVS RHHBY
Tags General Benzinga Biotech
From Benzinga
Move Over Magnificent 7, Say Hello to the GRANOLAS
Tickers AZN GLAXF LRLCY LVMUY
Tags GLAXF ASMLY NSRGY
From InvestorPlace
FDA Fast-Tracks Review Of Sarepta's Groundbreaking Muscular Dystrophy Treatment With $1B Market In Sight
Tickers NEWS RHHBY SRPT
Tags FDA Stories That Matter RHHBY
From Benzinga
Monte Rosa Therapeutics' AI And Machine Learning Platform Is Adding Significant Value Creation in Cancer Research: Analyst
Tickers GLUE NEWS RHHBY
Tags News Trading Ideas Health Care
From Benzinga
Roche Terminates Cancer Drug Pact With Repare Therapeutics, Its Second Walkout Within A Month
Tickers HOOK NEWS RHHBY RPTX
Tags Health Care News Large Cap
From Benzinga
Roche Walks Away From HOOKIPA Pharma-Partnered KRAS-Focused Cancer Deal
Tickers GILD HOOK MRK NEWS
Tags Biotech RHHBY MRK
From Benzinga
Roche's One Of Largest Selling Cancer Drug Approved Under The Skin Injection Version In Europe
Tickers HALO RHHBY
Tags Health Care Large Cap HALO
From Benzinga
Merck's Crown Jewel Cancer Drug Keytruda Scores FDA Approval For Third Indication In Cervical Cancer
Tickers MRK NEWS RHHBY
Tags Briefs Market News Health Care
From Benzinga
Is AI More Valuable In Advertising Than Healthcare? Jim Cramer Questions Wall Street's Preference
Tickers AMGN AMZN COR GOOGL
Tags NVDA AMZN COR
From Benzinga
2 Growth Stocks That Could Make You Richer in 2024 and Beyond
Tickers DXCM RHHBY SRPT
Tags Recent Press Releases SRPT Market News
From Motley Fool
Why Is LumiraDx (LMDX) Stock Down 13% Today?
Tickers CLRB HARP LMDX RHHBY
Tags Today's Market CLRB NASDAQ:LMDX,OTCMKTS:RHHBY,NASDAQ:CLRB,NASDAQ:HARP
From InvestorPlace
3 Great Foreign Companies to Invest in Right Now
Tickers ASML RHHBY TEAM
Tags RHHBY Market News ASML
From Motley Fool
Roche Agrees To Purchase Part Of COVID-19 Test Player LumiraDx Diagnostics Platform For $295M
Tickers LMDX NEWS RHHBF RHHBY
Tags RHHBF Movers Market News
From Benzinga
Weighing Their Chances: 5 Leading Healthcare Companies Fight for Market Share in the $100 Billion Weight-Loss Industry
Tickers AZN LLY NVO PFE
Tags PFE LLY Market News
From Motley Fool
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
Tickers CALT MCK NVS RHHBY
Tags News Health Care VERA
From Benzinga
This Big Pharma Is Teaming Up With Nvidia to Make Drugs With AI. Here's What You Need to Know
Tickers NVDA RHHBY
Tags NVDA Recent Press Releases RHHBY
From Motley Fool
Weight-Loss Drug Gold Rush Gets Larger As New Player Fractyl Health Files For $100M IPO
Tickers IPO IPOS NVO RHHBY
Tags NVO Market News Briefs
From Benzinga
The 3 Most Undervalued Biotech Stocks to Buy in December
Tickers INCY KNSA NBIX RHHBY
Tags Stocks to Buy NASDAQ:KNSA,OTCMKTS:RHHBY,NASDAQ:NBIX,NASDAQ:INCY Market News
From InvestorPlace
Poseida Therapeutics' New Treatment For Multiple Myeloma Shows Early Success In Clinical Trial
Tickers PSTX RHHBF RHHBY RHHVF
Tags Biotech RHHBY PSTX
From Benzinga
Why Viking Therapeutics Was Crushing It This Week
Tickers NVO RHHBY VKTX
Tags RHHBY NVO Market News
From Motley Fool
Altimmune’s stock pops as analysts see obesity-drug partnership potential
Tickers ALT AZN LLY NVO
Tags NVO RHHBY AZN
From MarketWatch
JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities
Tickers ALT JNJ LLY NVO
Tags Benzinga ALT General
From Benzinga
While Pfizer Faced A Setback, Altimmune, Roche And Mainz Biomed Advanced in The Battle Against Obesity And Colorectal Cancer
Tickers ALT MYNZ PFE RHHBY
Tags RHHBY Biotech Benzinga
From Benzinga
Roche's Combination Therapy Shows Improved Progression Free Survival In Certain Breast Cancer With Mutation
Tickers RHHBF RHHBY RHHVF
Tags Briefs Market News Biotech
From Benzinga
Jim Cramer Highlights 'Transformational' Impact Of Weight Loss Drugs Like Ozempic: Focus Now On 'Potential Winners' From The Same Narrative
Tickers LLY NVO RHHBY
Tags Eli Lilly & Co/ Novo Nordisk RHHBY
From Benzinga
Roche Joins Bandwagon To Challenge Novo Nordisk, Eli Lilly For Weight Loss Drugs
Tickers LLY NVO RHHBF RHHBY
Tags RHHVF LLY Health Care
From Benzinga
AstraZeneca Strikes Deal With Absci To Leverage AI In Cancer Drug Discovery: Report
Tickers ABSI AZN NVDA RHHBY
Tags General Contracts Media
From Benzinga
Ignore Crypto: These Stocks Could Make You Rich
Tickers MDT NEE RHHBY
Tags Recent Press Releases RHHBY NEE
From Motley Fool
Biotech Breakthroughs: 3 Revolutionary Stocks Redefining Healthcare
Tickers CLDX LUNG PSTX RHHBY
Tags CLDX NASDAQ:PSTX,NASDAQ:CLDX,NASDAQ:LUNG,OTCMKTS:RHHBY PSTX
From InvestorPlace
FDA Approves Bristol-Myers' Lung Cancer Drug Acquired Via $4B Turning Point Deal: Competes With Roche, Merck, AstraZeneca
Tickers AZN BMY MRK RHHBY
Tags MRK Biotech AZN
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.